The Scientific Committee published the first Agenda of the 8th World Conference on Targeting Phage Therapy, which will be held on June 10-11, 2025, at DoubleTree by Hilton Berlin Kudamm, Berlin, Germany. Read More
Short Communications 2025
The Lausanne University Hospital GMP production pipeline for manufacture of therapeutic bacteriophages
Gregory Resch, Lausanne University Hospital, Switzerland
Bacteriophage-based vaccine and IL-12 Gene Therapy Eradicate Aggressive Melanoma
Andrej Cör, Valdotra Orthopaedic Hospital, Slovenia
Collateral effects of bacteriophage resistance on antibiotic sensitivity in Pseudomonas aeruginosa
Laura Rianne Baars, Leiden University, Netherland
New Insights into Bacteriophage Therapy in Dogs
Eva Maria Kalbhenn, LABOKLIN GmbH & Co. KG, Germany
Biohybrid Composites of Platelet-Rich Fibrin and Gelatin Hydrogel Beads (Nano/Micro) for Targeted Phage Delivery in the Treatment of Infected Wounds
Farzaneh Moghtader, TiPhage, Turkey
Phage-Antibiotic Composite Efficacy on Dual-Species Biofilm
Tea Glonti, Queen Astrid Military Hospital, Belgium
Anti-Quorum Sensing Phages Rescue Galleria mellonella Larvae from Pseudomonas aeruginosa Infection
Kira Céline Koonce, University of Copenhagen, Denmark
Characterization and Genomic Analysis of a New Bacteriophage Klebsiella Pneumoniae CTF-1
Kübra Can Kurt, University of Health Science, Turkey
Disruption of Biofilm by selected Bacteriophages isolated from Environmental Samples
Filip Wojnarowski, Adam Mickiewicz University Poznań, Poland
Is the Nihil a Representative of A New Genus of Bacillus Viruses?
Jakub Barylski, Adam Mickiewicz University, Poznań, Poland
Isolation and Characterization of a Novel Bacteriophage Targeting Vancomycin-Resistant Enterococcus faecium
Laura Ribes-Martínez, Fundación Jiménez Díaz, Spain
Freeze-Dried Tablets for Therapeutic Application of Bacteriophages
Marie Komárková, Masaryk University, Czech Republic
Novel Mycobacteriophages as a Promising Adjunct in the Fight Against Drug-Resistant TB and NTM Infections
Anthony Vocat, Lausanne University Hospital, Switzerland
Characterization of Escherichia Coli Bacteriophages Isolated from Wastewater in Bulgaria
Yoana Krasimirova Kizheva, Sofia University “St. Kliment Ohridski”, Bulgaria
Epizootic Situation on Salmonellosis in Private Subsidiary Farms of The Republic of Kazakhstan
Bolat Yespembetov, Research institute for biological safety problems, Kazakhstan
Аn alternative approach to Syphilis Treatment: Bacteriophage against Treponema pallidum
Nazym Syrym, Research institute for biological safety problems, Kazakhstan
Genomic diversity of Bacteriophages infecting Cronobacter spp.
Hana Drahovska, Comenius University in Bratislava, Slovak Republic
Tailored phage selection for the treatment of chronic airway infections due to MDR Pseudomonas aeruginosa
Christian van Delden, University Hospitals Geneva, Switzerland
Two novel bacteriophages vB_Bm-S567 and vB_BoMT-1/77 targeting multidrug resistant Burkholderia cepacia complex
Sopiko Sturua, G. Eliava Institute of Bacteriophages, Microbiology and Virology, Georgia
A Multifaceted Experience with Phage Therapy: A Short Review of Successful and Challenging Cases Across Multiple Body Systems
Mariam Dadiani, Eliava Phage Therapy Center, Germany
Isolation, characterization and anti-biofilm activity of lytic bacteriophage K2 against Klebsiella pneumoniae isolates
Damla Damar Celik, Marmara University, Turkey
Successful Eradication of Chronic Pseudomonas aeruginosa Infection with Personalised Bacteriophage Therapy in Children with Cystic Fibrosis: An Early Phase Clinical Trial
Jagdev Singh, The Children’s Hospital at Westmead, Australia
Analysis of the profiles of pro- and anti-inflammatory response in patients subjected to phage therapy
Hubert Oskar Kasprzak, Hirszfeld Institute of Immunology and Experimental Therapy, Poland
Rapid and specific detection of pathogenic bacteria using recombinant receptor binding proteins of bacteriophages
Peter Braun, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Germany
Addressing phage resistance: Designing effective phage cocktails against multi-drug resistant Mycobacterium abscessus
Jun Hao Liew, ASTAR Infectious Diseases Lab/ASTAR, Singapore
Monitoring bacteriophage therapy using nuclear medicine imaging
Marek Mosa, Charles University – Faculty of Science, Czechia
Companies, Hospitals, Clinical Centers, and Industry Organizations
Jafral (Supporter)
Aptar Radolfzell GmbH
Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana
ArGe Teknoloji Sanayi ve Ticaret Anonim Şirketi
FagoFarma
TiPHAGE
Grachtenhaus-Apotheke e.K.
German Collection of Microorganisms and Cell Cultures GmbH
Kanzlei BRENNER
Komplementäre Tiermedizin GmbH
LABOKLIN GmbH & Co. KG
Laboklin Phage Center
Laboratorios Syva
MB Pharma
Medios AG
Inteliphage
Rime Bioinformatics
Phileo by Lesaffre
Phagos
Precise Health SA
Poulpharm
Salem Microbes
Academic Hospital Bundeswehr Berlin
Center de investigación en red – Enfermedades Respiratorias
Centre hospitalier universitaire vaudois
IIS-Fundación Jiménez Díaz and CIBERINFEC-Consorcio Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas
Federal research and clinical center of intensive care medicine and rehabilitology
Hannover Medical School
Shanghai Public Health Clinical Center
Victor Babes University of Medicine and Pharmacy Timisoara
Vivantes Klinik Bavaria Kreischa
Universities and Academic Institutions
Charles University
Charité – Universitätsmedizin Berlin
Comenius University in Bratislava
Delft University of Technology
Institute of Pharmacology and Toxicology, Veterinary Medicine
INSERM
Karadeniz Technical University
Nanyang Technological University
Leibniz Institute DSMZ
Masaryk University
Max Planck Inst Molecular Genetics
Monash University
HMU Health & Medical University Erfurt
Rakuno Gakuen University
Recep Tayyip Erdoğan University
Stockholm University
Tel Aviv University
UCLouvain
Università degli Studi di Milano
University of Bologna
University of California, San Diego
Université de Paris
University of Copenhagen
University of Helsinki
University of Milan
University of Pisa
University of Roma Tor Vergata
University of Southampton
University of Warwick
Vrije Universiteit Brussel
Yale University
This session provides a comprehensive and hands-on approach to the entire phage product lifecycle, from laboratory preparation to industrial-scale production and market entry. Experts will address both practical challenges and administrative requirements, ensuring that participants leave with actionable insights.
Key topics include: Technical & Manufacturing Aspects, Regulatory & Administrative Aspects, Business & Market Strategy.
The 7th World Conference on Targeting Phage Therapy 2024 on June 20-21 at Corinthia Palace in Malta was a great success. Over 40 presentations on the latest phage research were delivered to an audience of over 100 attendees representing 35 countries. Read more.